
EuroPCR 2023: Improving outcomes in mitral regurgitation
Francesco Maisano, Marianna Adamo, Alison Duncan, Georg Nickenig and Greg Stone discuss the role of COAPT trial evidence in reducing mitral regurgitation and securing optimal outcomes for patients. Points also discussed include patient selection, repair or replacement, and real-world registry evidence on reducing MR with TEER.
Related Videos

EuroPCR 2023: Tricuspid valve

EuroPCR 2023: COAPT 5-year follow-up

EuroPCR 2023: Vascular access

EuroPCR 2023: Defining the future

Transcatheter Mitral Valve implant

Navitor™: Voice of the Experts Maurizio Taramasso

M-TEER: patient selection and current evidence

TAVI Summit 2023: Aortic stenosis

ESC 2023 Tutorial – TriClip™ | Dr. Coisne

TAVI Case Club – Challenge of difficult access

AV VALVES 2023: Replace, Repair in TR

TAVI Summit - Cardiac imaging